← All trials
NCT06619990
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 10, 2024
- Primary completion
- Oct 31, 2026
- Completion date
- Oct 31, 2027
- First posted
- Oct 1, 2024
- Last posted
- Nov 4, 2024
- Enrollment
- 300
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Galena Biopharma, Inc.Lead sponsor
- XencorCollaborator
- Linear Clinical ResearchOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.